[The clinical trial of a prototype of the new LAR-2 serially produced laser optometer]

Based on results of clinical trials of a new commercial laser optometer LAR-2, the authors suggest methodologic recommendations for ametropia diagnosis making use of this apparatus. The new device can adequately solve the major refraction problems: express diagnosis of ametropia, specification of the optimal vision correction in selection of eyeglasses, assessment of dynamic refraction. LAR-2 was found useful in the treatment of vision fatigue and amblyopia. A conclusion is made about diagnostic and clinical fitness of LAR-2 laser optometer; some minor shortcomings of the device are to be eliminated.